|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
US5759830A
(en)
|
1986-11-20 |
1998-06-02 |
Massachusetts Institute Of Technology |
Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
|
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
EP0303681B1
(en)
|
1987-02-24 |
1992-10-14 |
Xoma Corporation |
Immunosuppression in immunotoxin based human therapy
|
|
US5912017A
(en)
|
1987-05-01 |
1999-06-15 |
Massachusetts Institute Of Technology |
Multiwall polymeric microspheres
|
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
JP2670680B2
(ja)
|
1988-02-24 |
1997-10-29 |
株式会社ビーエムジー |
生理活性物質含有ポリ乳酸系微小球およびその製造法
|
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
US5268455A
(en)
|
1989-05-25 |
1993-12-07 |
Genentech, Inc. |
Process for making biologically active polypeptides based on transforming growth factor-βsequences
|
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
US5843452A
(en)
|
1992-11-09 |
1998-12-01 |
Pharmagenesis, Inc. |
Immunotherapy composition and method
|
|
US5679347A
(en)
|
1992-12-10 |
1997-10-21 |
Brigham And Women's Hospital |
Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
|
|
DE69418699T2
(de)
|
1993-01-11 |
1999-09-30 |
Dana-Farber Cancer Institute, Boston |
Induktion der antworten zytotoxischer t-lymphozyten
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
WO1995003035A1
(en)
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
|
TW249754B
(enExample)
|
1993-10-26 |
1995-06-21 |
Alpha I Biomedicals Inc |
|
|
CA2190494C
(en)
|
1994-05-18 |
2002-05-07 |
Michael E. Houston |
Heterodimer polypeptide immunogen carrier composition and method
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5814617A
(en)
|
1994-10-07 |
1998-09-29 |
The United States Of America As Represented By The Secretary Of The Navy |
Protective 17 KDA malaria hepatic and erythrocytic stage immunogen and gene
|
|
JPH10507758A
(ja)
|
1994-10-19 |
1998-07-28 |
ジェネティック セラピー，インコーポレイテッド |
アデノウイルスおよび免疫抑制剤同時反復投与を伴う遺伝子治療
|
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
CA2207961A1
(en)
|
1995-01-05 |
1996-07-11 |
Robert J. Levy |
Surface-modified nanoparticles and method of making and using same
|
|
US6251957B1
(en)
|
1995-02-24 |
2001-06-26 |
Trustees Of The University Of Pennsylvania |
Method of reducing an immune response to a recombinant virus
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
JP3462313B2
(ja)
|
1995-08-24 |
2003-11-05 |
キッコーマン株式会社 |
変異型ウリカーゼ、変異型ウリカーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ウリカーゼの製造法
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
EP0937082A2
(en)
|
1996-07-12 |
1999-08-25 |
Ariad Pharmaceuticals, Inc. |
Materials and method for treating or preventing pathogenic fungal infection
|
|
AU4176497A
(en)
|
1996-09-03 |
1998-03-26 |
Health Research Inc. |
Treatment of antigen presenting cells to modulate antigen presenting cell fun ction
|
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
ES2323098T3
(es)
|
1997-09-16 |
2009-07-06 |
Oregon Health And Science University |
Moleculas de mhc recombinantes utiles para la manipulacion de celulas t especificas de antigeno.
|
|
CA2307655C
(en)
|
1997-10-30 |
2005-05-24 |
C.B.F. Leti S.A. |
Tolerogenic fragments of natural allergens
|
|
US6018817A
(en)
|
1997-12-03 |
2000-01-25 |
International Business Machines Corporation |
Error correcting code retrofit method and apparatus for multiple memory configurations
|
|
US6197229B1
(en)
|
1997-12-12 |
2001-03-06 |
Massachusetts Institute Of Technology |
Method for high supercoiled DNA content microspheres
|
|
NZ505325A
(en)
|
1997-12-23 |
2003-07-25 |
Crucell Holland B |
Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells
|
|
CA2317724A1
(en)
|
1998-01-09 |
1999-07-15 |
Circassia Limited |
Methods and compositions for desensitisation
|
|
FR2775435B1
(fr)
|
1998-02-27 |
2000-05-26 |
Bioalliance Pharma |
Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
|
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
SE9801288D0
(sv)
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
RU2278680C2
(ru)
|
1998-08-06 |
2006-06-27 |
Маунтэн Вью Фармасьютикэлз, Инк. |
Способ изолирования тетрамерной формы уриказы и уриказа, полученная данным способом
|
|
DE69918146T2
(de)
|
1998-10-05 |
2005-07-07 |
Pharmexa A/S |
Verfahren zur therapeutischen impfung
|
|
US6306640B1
(en)
|
1998-10-05 |
2001-10-23 |
Genzyme Corporation |
Melanoma antigenic peptides
|
|
WO2000024770A2
(en)
|
1998-10-23 |
2000-05-04 |
Amgen Inc. |
Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
US6395511B1
(en)
|
1998-11-27 |
2002-05-28 |
Darwin Discovery, Ltd. |
Nucleic acids encoding a novel family of TGF-β binding proteins from humans
|
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
|
US6153217A
(en)
|
1999-01-22 |
2000-11-28 |
Biodelivery Sciences, Inc. |
Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
|
|
US6800296B1
(en)
|
1999-05-19 |
2004-10-05 |
Massachusetts Institute Of Technology |
Modification of surfaces using biological recognition events
|
|
WO2000074688A1
(en)
|
1999-06-08 |
2000-12-14 |
The Children's Hospital Of Philadelphia |
Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
|
|
DE19951970A1
(de)
|
1999-10-28 |
2001-05-03 |
Bionetworks Gmbh |
Arzneimittel für die Toleranzinduktion
|
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス， インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
|
WO2001068133A1
(en)
|
2000-03-14 |
2001-09-20 |
Genetics Institute, Inc. |
Use of rapamycin and agents that inhibit b7 activity in immunomodulation
|
|
CA2407897A1
(en)
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
AU2001265187A1
(en)
|
2000-05-30 |
2001-12-11 |
Baylor College Of Medicine |
Chimeric viral vectors for gene therapy
|
|
WO2001092551A2
(en)
|
2000-06-01 |
2001-12-06 |
University Of North Carolina At Chapel Hill |
Duplexed parvovirus vectors
|
|
US20040204379A1
(en)
|
2000-06-19 |
2004-10-14 |
Cheng Seng H. |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
US20020095135A1
(en)
|
2000-06-19 |
2002-07-18 |
David Meeker |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
US20020014242A1
(en)
|
2000-07-31 |
2002-02-07 |
Abraham Scaria |
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
|
|
MY138883A
(en)
|
2000-08-29 |
2009-08-28 |
Government Of Malaysia As Represented By The Ministry Of Science Tehnology And Innovation Malaysia |
Use of asiatic acid for treatment of cencer
|
|
CA2319928A1
(en)
|
2000-09-18 |
2002-03-18 |
Vasogen Ireland Limited |
Apoptosis-mimicking synthetic entities and use thereof in medical treatments
|
|
GB0025414D0
(en)
|
2000-10-16 |
2000-11-29 |
Consejo Superior Investigacion |
Nanoparticles
|
|
AU2002338571A1
(en)
|
2001-04-11 |
2002-11-11 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for suppressing immune responses
|
|
US6913915B2
(en)
|
2001-08-02 |
2005-07-05 |
Phoenix Pharmacologics, Inc. |
PEG-modified uricase
|
|
US6818732B2
(en)
|
2001-08-30 |
2004-11-16 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
CN1294268C
(zh)
|
2001-09-03 |
2007-01-10 |
上海三维生物技术有限公司 |
可在肿瘤细胞内特异性复制并扩散的重组腺病毒载体
|
|
CN100334106C
(zh)
|
2001-10-19 |
2007-08-29 |
伊索泰克尼卡股份有限公司 |
环孢菌素类似物的合成
|
|
JP4810062B2
(ja)
|
2001-12-17 |
2011-11-09 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
アデノ随伴ウイルス（ａａｖ）血清型８の配列
|
|
GB0207440D0
(en)
|
2002-03-28 |
2002-05-08 |
Ppl Therapeutics Scotland Ltd |
Tolerogenic antigen-presenting cells
|
|
US20040038303A1
(en)
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
|
US7485314B2
(en)
|
2002-05-06 |
2009-02-03 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Induction of antigen specific immunologic tolerance
|
|
US20040005315A1
(en)
|
2002-05-22 |
2004-01-08 |
Siemionow Maria Z. |
Induction and maintenance of tolerance to composite tissue allografts
|
|
US20040043483A1
(en)
|
2002-06-04 |
2004-03-04 |
Shiguang Qian |
Novel tolerogenic dendritic cells and therapeutic uses therefor
|
|
SG167667A1
(en)
|
2002-07-03 |
2011-01-28 |
Coley Pharm Group Inc |
Nucleic acid compositions for stimulating immune responses
|
|
US9809654B2
(en)
|
2002-09-27 |
2017-11-07 |
Vaccinex, Inc. |
Targeted CD1d molecules
|
|
ES2312820T3
(es)
|
2002-11-29 |
2009-03-01 |
Maria Grazia Roncarolo |
Paramicina e il-10 para el tratamiento de enfermedades autoinmunes.
|
|
JP4509999B2
(ja)
|
2003-02-17 |
2010-07-21 |
ブルクハルト，ペーター |
医薬送達及び抗原提示システムとしてのペプチドナノ粒子
|
|
WO2004075861A2
(en)
|
2003-02-26 |
2004-09-10 |
Children's Hospital, Inc. |
Recombinant adeno-associated virus production
|
|
DE602004025332D1
(de)
|
2003-03-14 |
2010-03-18 |
Wyeth Corp |
Antikörper gegen il21-rezeptor und deren verwendung
|
|
ZA200507562B
(en)
|
2003-03-26 |
2006-11-29 |
Cytos Biotechnology Ag |
HIV-peptide-carrier-conjugates
|
|
US7186699B2
(en)
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
|
EA015166B1
(ru)
|
2003-06-16 |
2011-06-30 |
Ю-Си-Би Мэньюфэкчуринг, Инк. |
Иммуногенные пептиды склеростина (sost), индуцирующие образование специфических антител
|
|
US20060251711A1
(en)
|
2003-08-28 |
2006-11-09 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating diseases of the respiratory tract of a mammal
|
|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
US20080160089A1
(en)
|
2003-10-14 |
2008-07-03 |
Medivas, Llc |
Vaccine delivery compositions and methods of use
|
|
AU2004311630A1
(en)
|
2003-12-02 |
2005-07-21 |
Cytimmune Sciences, Inc. |
Methods and compositions for the production of monoclonal antibodies
|
|
KR20120105062A
(ko)
|
2003-12-19 |
2012-09-24 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
소프트 또는 임프린트 리소그래피를 이용하여 분리된 마이크로- 및 나노- 구조를 제작하는 방법
|
|
US20080039377A1
(en)
|
2004-04-08 |
2008-02-14 |
Applied Research Systems Ars Holding N.V. |
Composition Comprising a Jnk Inhibitor and Cyclosporin
|
|
EP1756147A2
(en)
|
2004-06-01 |
2007-02-28 |
Innogenetics N.V. |
Peptides for inducing a ctl and/or htl response to hepatitis c virus
|
|
JP2008512350A
(ja)
|
2004-07-01 |
2008-04-24 |
イェール ユニバーシティ |
標的化され、そして高密度で薬物が負荷されるポリマー性物質
|
|
WO2006014579A2
(en)
|
2004-07-08 |
2006-02-09 |
The Regents Of California |
Enhancing class i antigen presentation with synthetic sequences
|
|
FR2874384B1
(fr)
|
2004-08-17 |
2010-07-30 |
Genethon |
Vecteur viral adeno-associe pour realiser du saut d'exons dans un gene codant une proteine a domaines dispensables
|
|
JP2008515806A
(ja)
|
2004-10-05 |
2008-05-15 |
タノックス インコーポレイテッド |
代償療法を受けている患者における過敏症および／またはアナフィラキシーの抗ＩｇＥ抗体による処置および予防
|
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
MX2007007342A
(es)
|
2004-12-15 |
2007-12-11 |
Elan Pharma Int Ltd |
Formulaciones de tacrolimus nanoparticuladas.
|
|
NZ555719A
(en)
|
2004-12-31 |
2010-11-26 |
Iceutica Pty Ltd |
Nanoparticle composition and methods for synthesis thereof
|
|
GB0504206D0
(en)
|
2005-03-01 |
2005-04-06 |
Glaxo Group Ltd |
Combination therapy
|
|
CN101137365A
(zh)
|
2005-03-08 |
2008-03-05 |
生命周期药物公司 |
包含西罗莫司和/或其类似物的药物组合物
|
|
EP1868576A2
(en)
|
2005-03-17 |
2007-12-26 |
Elan Pharma International Limited |
Injectable compositions of nanoparticulate immunosuppressive compounds
|
|
US7884109B2
(en)
|
2005-04-05 |
2011-02-08 |
Wyeth Llc |
Purine and imidazopyridine derivatives for immunosuppression
|
|
AU2006235538A1
(en)
|
2005-04-12 |
2006-10-19 |
Wisconsin Alumni Research Foundation |
Micelle composition of polymer and passenger drug
|
|
EP1893661B1
(en)
|
2005-05-10 |
2012-01-18 |
Emory University |
Strategies for delivery of active agents using micelles and particles
|
|
TW200711649A
(en)
|
2005-06-17 |
2007-04-01 |
Combinatorx Inc |
Combination therapy for the treatment of immunoinflammatory disorders
|
|
JP5570721B2
(ja)
|
2005-06-17 |
2014-08-13 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
ナノ粒子の製造方法、システム、及び材料
|
|
WO2007024026A1
(ja)
|
2005-08-25 |
2007-03-01 |
Taiho Pharmaceutical Co., Ltd. |
Ｔ細胞認識エピトープペプチドを固定化又は内包化した生分解性ナノ粒子
|
|
CN1979166A
(zh)
|
2005-11-30 |
2007-06-13 |
北京有色金属研究总院 |
一种制备免疫检测用纳米胶体金的工艺方法及其反应装置
|
|
US20070202077A1
(en)
|
2005-12-02 |
2007-08-30 |
Brodsky Robert A |
Use of High-Dose Oxazaphosphorine Drugs for Treating Immune Disorders
|
|
US20070128289A1
(en)
|
2005-12-07 |
2007-06-07 |
Zhao Jonathon Z |
Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases
|
|
EP1973573B1
(en)
|
2005-12-08 |
2013-05-22 |
University of Louisville Research Foundation, Inc. |
Methods and compositions for expanding t regulatory cells
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
WO2007087341A2
(en)
|
2006-01-25 |
2007-08-02 |
The Board Of Trustees Of The University Of Illinois |
Tolerogenic biodegradable artificial antigen presenting system
|
|
WO2007093036A1
(en)
|
2006-02-13 |
2007-08-23 |
Oncolytics Biotech Inc. |
Use of local immune suppression to enhance oncolytic viral therapy
|
|
US8021689B2
(en)
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
|
US8568487B2
(en)
|
2006-02-27 |
2013-10-29 |
Biomet Manufacturing, Llc |
Patient-specific hip joint devices
|
|
KR20090008290A
(ko)
|
2006-03-27 |
2009-01-21 |
글로브이뮨 |
Ｒａｓ 돌연변이와 그에 관련된 조성물 및 방법
|
|
CA2650607A1
(en)
|
2006-04-28 |
2007-11-08 |
Resolvyx Pharmaceuticals, Inc. |
Compositions and methods for the treatment of cardiovascular disease
|
|
EP2019691B1
(en)
|
2006-05-15 |
2020-08-12 |
Massachusetts Institute of Technology |
Polymers for functional particles
|
|
US20110052697A1
(en)
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
|
EP1880729A1
(en)
|
2006-07-20 |
2008-01-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of soluble CD160 to suppress immunity
|
|
US20140010821A1
(en)
|
2006-08-18 |
2014-01-09 |
Aili Lao |
Use of CD83 in combination therapies
|
|
WO2008036374A2
(en)
|
2006-09-21 |
2008-03-27 |
Medistem Laboratories, Inc. |
Allogeneic stem cell transplants in non-conditioned recipients
|
|
JP2010505877A
(ja)
|
2006-10-05 |
2010-02-25 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
スマートな高分子ナノ粒子を用いた低水溶性薬物用の水分散性経口、非経口および局所的製剤
|
|
CN101646418B
(zh)
|
2006-10-12 |
2013-07-17 |
昆士兰大学 |
调节免疫应答的组合物和方法
|
|
EP2077821B1
(en)
|
2006-10-12 |
2019-08-14 |
The University Of Queensland |
Compositions and methods for modulating immune responses
|
|
US20100112077A1
(en)
|
2006-11-06 |
2010-05-06 |
Abraxis Bioscience, Llc |
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
|
|
WO2008064357A2
(en)
|
2006-11-22 |
2008-05-29 |
University Of Florida Research Foundation, Inc. |
Nanoparticles for protection of cells from oxidative stress
|
|
WO2008069942A2
(en)
|
2006-12-05 |
2008-06-12 |
Biogen Idec Ma Inc. |
Novel methods of enhancing delivery of a gene therapy vector using steroids
|
|
CN101646781B
(zh)
|
2006-12-29 |
2016-06-22 |
科罗拉多大学董事会 |
自身免疫病的诊断和治疗靶标及其用途
|
|
WO2008103392A2
(en)
|
2007-02-21 |
2008-08-28 |
Vaccinex, Inc. |
Modulation of nkt cell activity with antigen-loaded cdid molecules
|
|
KR20080078204A
(ko)
|
2007-02-22 |
2008-08-27 |
크레아젠 주식회사 |
면역억제능이 증가된 간엽줄기세포-매개 자가유래수지상세포
|
|
EP2131856B1
(en)
|
2007-03-07 |
2014-09-17 |
UTI Limited Partnership |
Compositions and methods for the prevention and treatment of autoimmune conditions
|
|
LT2481409T
(lt)
|
2007-03-07 |
2018-10-25 |
Abraxis Bioscience, Llc |
Nanodalelės, apimančios rapamiciną ir albuminą, kaip priešvėžinį agentą
|
|
CN101730526A
(zh)
|
2007-03-07 |
2010-06-09 |
阿布拉科斯生物科学有限公司 |
作为抗癌剂的包含雷帕霉素和白蛋白的纳米颗粒
|
|
CN103120653B
(zh)
|
2007-04-04 |
2015-09-30 |
希格默伊德药业有限公司 |
一种口服药物组合物
|
|
US20090074828A1
(en)
|
2007-04-04 |
2009-03-19 |
Massachusetts Institute Of Technology |
Poly(amino acid) targeting moieties
|
|
US20090226525A1
(en)
|
2007-04-09 |
2009-09-10 |
Chimeros Inc. |
Self-assembling nanoparticle drug delivery system
|
|
SE531313C2
(sv)
|
2007-05-25 |
2009-02-17 |
Totalfoersvarets Forskningsins |
Piezokrom komposit
|
|
US20080311140A1
(en)
|
2007-05-29 |
2008-12-18 |
Baylor College Of Medicine |
Antigen specific immunosuppression by dendritic cell therapy
|
|
WO2008150868A1
(en)
|
2007-05-29 |
2008-12-11 |
The Board Of Trustees Of The University Of Illinois |
Methods for inducing therapeutic t cells for immune diseases
|
|
CA3167595A1
(en)
|
2007-05-31 |
2008-12-04 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines
|
|
US20100183602A1
(en)
|
2007-06-05 |
2010-07-22 |
Novartis Ag |
Induction of Tolerogenic Phenotype in Mature Dendritic Cells
|
|
US20090004259A1
(en)
|
2007-06-14 |
2009-01-01 |
Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) |
Methods of preparing a therapeutic formulation comprising galectin-induced tolerogenic dendritic cells
|
|
ATE554075T1
(de)
|
2007-07-09 |
2012-05-15 |
Astrazeneca Ab |
Bei mit mtor-kinase und/oder pi3k in zusammenhang stehenden krankheiten angewendete morpholinopyrimidinderivate
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
CN103272227B
(zh)
|
2007-08-15 |
2014-12-10 |
切尔卡西亚有限公司 |
针对过敏原去敏化的肽
|
|
AU2008302035A1
(en)
|
2007-09-21 |
2009-03-26 |
Cytimmune Sciences, Inc. |
Nanotherapeutic colloidal metal compositions and methods
|
|
MX350501B
(es)
|
2007-10-12 |
2017-09-07 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
|
WO2009062502A1
(en)
|
2007-11-13 |
2009-05-22 |
Dandrit Biotech A/S |
Method for generating tolerogenic dendritic cells employing decreased temperature
|
|
US20090142318A1
(en)
|
2007-11-30 |
2009-06-04 |
Therakos, Inc. |
METHOD TO EXPAND nTREG CELLS USING p70 S6 KINASE ANTAGONIST
|
|
US8404658B2
(en)
|
2007-12-31 |
2013-03-26 |
Nanocor Therapeutics, Inc. |
RNA interference for the treatment of heart failure
|
|
EP2249900A4
(en)
|
2008-02-08 |
2013-11-06 |
Terumo Corp |
DEVICE FOR LOCAL INTRALUMINAL TRANSPORT OF A BIOLOGICALLY AND PHYSIOLOGICALLY ACTIVE AGENCY
|
|
WO2009106999A2
(en)
|
2008-02-28 |
2009-09-03 |
Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts |
Hollow nanoparticles and uses thereof
|
|
EP2300022A2
(en)
|
2008-04-25 |
2011-03-30 |
Duke University |
Regulatory b cells and their uses
|
|
CA2724418A1
(en)
|
2008-05-15 |
2009-11-19 |
Dynavax Technologies Corporation |
Long term disease modification using immunostimulatory oligonucleotides
|
|
JP5549014B2
(ja)
|
2008-05-27 |
2014-07-16 |
国立大学法人名古屋大学 |
免疫調節剤及びその利用
|
|
US20090297621A1
(en)
|
2008-06-03 |
2009-12-03 |
Abbott Cardiovascular Systems Inc. |
Microparticles For The Treatment Of Disease
|
|
US8613951B2
(en)
|
2008-06-16 |
2013-12-24 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
|
|
US8206747B2
(en)
|
2008-06-16 |
2012-06-26 |
Bind Biosciences, Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
|
US20120034157A1
(en)
|
2010-08-03 |
2012-02-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Artificial cells
|
|
EP2331124A1
(en)
|
2008-08-15 |
2011-06-15 |
Circassia Limited |
T-cell antigen peptide from allergen for stimulation of il-10 production
|
|
US8323696B2
(en)
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
|
EP2341953B1
(en)
|
2008-09-04 |
2018-11-21 |
The General Hospital Corporation |
Hydrogels for vocal cord and soft tissue augmentation and repair
|
|
CN101676291B
(zh)
|
2008-09-18 |
2012-05-09 |
上海海和药物研究开发有限公司 |
一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途
|
|
US8889124B2
(en)
|
2008-09-25 |
2014-11-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Tolerogenic populations of dendritic cells
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
JP5552630B2
(ja)
|
2008-10-24 |
2014-07-16 |
学校法人 聖マリアンナ医科大学 |
Ｈｔｌｖ−ｉ関連脊髄症を治療または予防するための医薬、およびｈｔｌｖ−ｉ関連脊髄症の患者に対する抗体療法の効果を試験する方法
|
|
WO2010047839A1
(en)
|
2008-10-25 |
2010-04-29 |
Aura Biosciences |
Modified plant virus particles and uses therefor
|
|
WO2010056143A1
(en)
|
2008-11-13 |
2010-05-20 |
Instituto De Medicina Molecular |
The use of adjuvant to facilitate the induction of immune tolerance
|
|
ES2776126T3
(es)
|
2008-12-15 |
2020-07-29 |
Pfizer |
Nanopartículas de circulación prolongada para la liberación sostenida de agentes terapéuticos
|
|
US20120076831A1
(en)
|
2009-01-20 |
2012-03-29 |
Stephen Miller |
Compositions and methods for induction of antigen-specific tolerance
|
|
EP2218784A1
(en)
|
2009-02-04 |
2010-08-18 |
Universität Leipzig |
Vector(s) containing an inducible gene encoding a CDK4/CD6 inhibitor useful for treating neurodegenerative disorders
|
|
GB2469894B
(en)
|
2009-02-05 |
2011-09-07 |
Circassia Ltd |
Peptides for use in treating allergy to grass pollen
|
|
KR20100099849A
(ko)
|
2009-03-04 |
2010-09-15 |
동국대학교 산학협력단 |
면역억제제와 트랜스글루타미나제 2의 억제제를 함유한 아토피 피부염 치료용 조성물
|
|
WO2010114948A2
(en)
|
2009-04-02 |
2010-10-07 |
University Of Florida Research Foundation, Inc. |
An inducible system for highly efficient production of recombinant adeno-associated virus (raav) vectors
|
|
GB0906159D0
(en)
|
2009-04-09 |
2009-05-20 |
Summit Corp Plc |
Drug combination for the treatment of proteostatic diseases
|
|
CA2759332A1
(en)
|
2009-04-21 |
2010-10-28 |
Selecta Biosciences, Inc. |
Immunonanotherapeutics providing a th1-biased response
|
|
EP2421563B1
(en)
|
2009-04-22 |
2017-04-12 |
Massachusetts Institute of Technology |
Innate immune suppression enables repeated delivery of long rna molecules
|
|
EP2424890B1
(en)
|
2009-04-27 |
2018-08-01 |
Immuron Limited |
Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of non alcoholic steatohepatitis
|
|
EA022699B1
(ru)
|
2009-05-27 |
2016-02-29 |
Селекта Байосайенсиз, Инк. |
НАЦЕЛЕННЫЕ СИНТЕТИЧЕСКИЕ НАНОНОСИТЕЛИ С pH-ЧУВСТВИТЕЛЬНЫМ ВЫСВОБОЖДЕНИЕМ ИММУНОМОДУЛИРУЮЩИХ СРЕДСТВ
|
|
US9377454B2
(en)
|
2009-06-25 |
2016-06-28 |
Crealta Pharmaceuticals Llc |
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
|
|
WO2011031298A1
(en)
|
2009-08-26 |
2011-03-17 |
Selecta Biosciences, Inc. |
Compositions that induce t cell help
|
|
AR078161A1
(es)
|
2009-09-11 |
2011-10-19 |
Hoffmann La Roche |
Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
|
|
EP2305277A1
(en)
|
2009-09-18 |
2011-04-06 |
Forskarpatent I Syd AB |
Use of tolerogenic dendritic cells in treatment and prevention of atherosclerosis
|
|
CN101703781A
(zh)
|
2009-10-28 |
2010-05-12 |
陕西北美基因股份有限公司 |
一种免疫抑制剂的磁性载药方法
|
|
KR101267813B1
(ko)
|
2009-12-30 |
2013-06-04 |
주식회사 삼양바이오팜 |
향상된 수용해도를 갖는 라파마이신 함유 고분자나노입자 주사제형 조성물 및 그 제조방법, 및 방사선 요법과 병용하기 위한 항암 조성물
|
|
WO2011085231A2
(en)
|
2010-01-08 |
2011-07-14 |
Selecta Biosciences, Inc. |
Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
|
|
WO2011097511A1
(en)
|
2010-02-05 |
2011-08-11 |
The United States Of America, As Represented By The Secretary Department Of Health & Human Services |
REGULATORY B CELLS (tBREGS) AND THEIR USE
|
|
JP2013521002A
(ja)
|
2010-03-05 |
2013-06-10 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
誘導樹状細胞組成物及びその使用
|
|
US20110272836A1
(en)
|
2010-04-12 |
2011-11-10 |
Selecta Biosciences, Inc. |
Eccentric vessels
|
|
US20110262491A1
(en)
|
2010-04-12 |
2011-10-27 |
Selecta Biosciences, Inc. |
Emulsions and methods of making nanocarriers
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
EA201201526A1
(ru)
|
2010-05-07 |
2013-06-28 |
Ксома Текнолоджи Лтд. |
Способы лечения состояний, связанных с il-1b
|
|
CN106177940A
(zh)
|
2010-05-26 |
2016-12-07 |
西莱克塔生物科技公司 |
含有佐剂的合成纳米载体的剂量选择
|
|
MY166014A
(en)
|
2010-06-07 |
2018-05-21 |
Abraxis Bioscience Llc |
Combination therapy methods for treating proliferative diseases
|
|
US10131875B2
(en)
|
2010-08-04 |
2018-11-20 |
Duke University |
Regulatory B cells and their uses
|
|
CN108117586A
(zh)
|
2010-08-10 |
2018-06-05 |
洛桑聚合联合学院 |
红细胞结合性治疗剂
|
|
US20120058153A1
(en)
|
2010-08-20 |
2012-03-08 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin
|
|
WO2012027365A2
(en)
|
2010-08-23 |
2012-03-01 |
Selecta Biosciences, Inc. |
Targeted multi-epitope dosage forms for induction of an immune response to antigens
|
|
CA2810842C
(en)
|
2010-09-09 |
2018-06-26 |
Micell Technologies, Inc. |
Macrolide dosage forms
|
|
US10016371B2
(en)
|
2010-10-22 |
2018-07-10 |
University Of Florida Research Foundation |
Antigen-specific, tolerance-inducing microparticles and uses thereof
|
|
US9994443B2
(en)
|
2010-11-05 |
2018-06-12 |
Selecta Biosciences, Inc. |
Modified nicotinic compounds and related methods
|
|
WO2012092552A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
|
CN103501793A
(zh)
|
2011-02-08 |
2014-01-08 |
夏洛特-梅克伦堡医院(商业用名:卡罗来纳保健系统) |
反义寡核苷酸
|
|
US10392632B2
(en)
|
2011-02-14 |
2019-08-27 |
The Children's Hospital Of Philadelphia |
AAV8 vector with enhanced functional activity and methods of use thereof
|
|
US8654487B2
(en)
|
2011-03-11 |
2014-02-18 |
Siemens Industry, Inc. |
Methods, systems, and apparatus and for detecting parallel electrical arc faults
|
|
CA2830948A1
(en)
|
2011-03-25 |
2012-10-04 |
Selecta Biosciences, Inc. |
Osmotic mediated release synthetic nanocarriers
|
|
WO2012145509A2
(en)
|
2011-04-19 |
2012-10-26 |
The Research Foundation Of State University Of New York |
Adeno-associated-virus rep sequences, vectors, and viruses
|
|
EP2699688A1
(en)
|
2011-04-20 |
2014-02-26 |
The Trustees Of The University Of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
|
AU2012249553A1
(en)
|
2011-04-29 |
2013-10-24 |
Selecta Biociences, Inc. |
Tolerogenic synthetic nanocarriers for allergy therapy
|
|
MX2013013445A
(es)
|
2011-05-16 |
2014-07-28 |
Genzyme Corp |
Induccion de tolerancia inmunologica utilizando metotrexato.
|
|
KR20140050698A
(ko)
|
2011-07-29 |
2014-04-29 |
셀렉타 바이오사이언시즈, 인크. |
체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
|
|
WO2013036303A2
(en)
|
2011-09-06 |
2013-03-14 |
Selecta Biosciences, Inc. |
Induced tolerogenic dendritic cells to reduce systemic inflammatory cytokines
|
|
US9913830B2
(en)
|
2011-09-08 |
2018-03-13 |
University Of Florida Research Foundation, Incorporated |
Materials and methods for modulating immune responses
|
|
US8865487B2
(en)
|
2011-09-20 |
2014-10-21 |
General Electric Company |
Large area hermetic encapsulation of an optoelectronic device using vacuum lamination
|
|
WO2013058812A1
(en)
|
2011-10-19 |
2013-04-25 |
President And Fellows Of Harvard College |
Targeted delivery to pancreatic islet endothelial cells
|
|
EP2591801A1
(en)
|
2011-11-14 |
2013-05-15 |
Universitätsklinikum Hamburg-Eppendorf |
Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
|
|
US10640785B2
(en)
|
2011-11-22 |
2020-05-05 |
The Children's Hospital Of Philadelphia |
Virus vectors for highly efficient transgene delivery
|
|
CN104520428B
(zh)
|
2012-02-17 |
2018-09-21 |
费城儿童医院 |
将基因转移到细胞、器官和组织的aav载体组合物和方法
|
|
CA2870736C
(en)
|
2012-04-18 |
2021-11-02 |
The Children's Hospital Of Philadelphia |
Composition and methods for highly efficient gene transfer using aav capsid variants
|
|
CN104797269A
(zh)
|
2012-04-24 |
2015-07-22 |
俄亥俄州国家创新基金会 |
用于治疗和预防猪繁殖与呼吸综合征的组合物和方法
|
|
EP2895146A1
(en)
|
2012-09-17 |
2015-07-22 |
BIND Therapeutics, Inc. |
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
|
|
CN102871966B
(zh)
|
2012-10-19 |
2013-11-20 |
东南大学 |
用于改善雷帕霉素生物利用度的纳米载药颗粒及其制备方法
|
|
US9944918B2
(en)
|
2013-03-15 |
2018-04-17 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)
|
|
EP2968499A4
(en)
|
2013-03-15 |
2016-11-30 |
Haplomics Inc |
COMPOSITIONS AND METHODS FOR THE IMMUNO-TOLERANCE INDUCTION FOR FACTOR VIII SPATIAL THERAPIES IN PERSONS WITH HEMOPHILIA A
|
|
AU2014251099B2
(en)
|
2013-04-08 |
2019-01-17 |
The University Of Kansas |
Chimeric adeno-associated virus/ bocavirus parvovirus vector
|
|
AU2014262164B2
(en)
|
2013-05-03 |
2020-02-27 |
Selecta Biosciences, Inc. |
Dosing combinations for reducing undesired humoral immune responses
|
|
MX2015015231A
(es)
|
2013-05-03 |
2016-07-06 |
Selecta Biosciences Inc |
Métodos y composiciones para mejorar las células t reguladoras de cd4+.
|
|
KR102631173B1
(ko)
|
2013-06-04 |
2024-01-31 |
셀렉타 바이오사이언시즈, 인크. |
비-면역억제성 항원 특이적 면역요법제의 반복 투여
|
|
US9388222B2
(en)
|
2013-10-06 |
2016-07-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modified Pseudomonas exotoxin A
|
|
US9276815B2
(en)
|
2013-12-27 |
2016-03-01 |
Dell Products L.P. |
N-node virtual link trunking (VLT) systems management plane
|
|
EP2916319A1
(en)
|
2014-03-07 |
2015-09-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Concept for encoding of information
|
|
SI3116900T1
(sl)
|
2014-03-09 |
2021-02-26 |
The Trustees Of The University Of Pennsylvania |
Sestavki uporabni pri zdravljenju pomanjkanja ornitin transkarbamilaze(OTC)
|
|
GB201407322D0
(en)
|
2014-04-25 |
2014-06-11 |
Ospedale San Raffaele |
Gene therapy
|
|
US20150359865A1
(en)
|
2014-06-17 |
2015-12-17 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers for t-cell-mediated autoimmune disease
|
|
US20160220501A1
(en)
|
2015-02-03 |
2016-08-04 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
|
|
AU2015279738A1
(en)
|
2014-06-25 |
2016-12-22 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
|
IL292575A
(en)
|
2014-09-07 |
2022-06-01 |
Selecta Biosciences Inc |
Methods and preparations for weakening immune responses by modulating gene expression in an antiviral transfer system
|
|
AU2015330092A1
(en)
|
2014-10-06 |
2017-04-13 |
Arthrogen B.V. |
AAV-based gene therapy
|
|
CA2966850C
(en)
|
2014-11-05 |
2024-03-26 |
Selecta Biosciences, Inc. |
Methods and compositions related to the use of low hlb surfactants in the production of synthetic nanocarriers comprising a rapalog
|
|
WO2017010567A1
(ja)
|
2015-07-15 |
2017-01-19 |
協和発酵キリン株式会社 |
ヒトｃｒｔｈ２に特異的に結合する抗体
|
|
WO2017139212A1
(en)
|
2016-02-08 |
2017-08-17 |
Cyta Therapeutics, Inc. |
Particle delivery of rapamycin to the liver
|
|
WO2017138983A1
(en)
|
2016-02-10 |
2017-08-17 |
Pfizer Inc. |
Therapeutic nanoparticles having egfr ligands and methods of making and using same
|
|
WO2017156513A1
(en)
|
2016-03-11 |
2017-09-14 |
Selecta Biosciences, Inc. |
Formulations and doses of pegylated uricase
|
|
GB201608323D0
(en)
|
2016-05-12 |
2016-06-29 |
Ucb Biopharma Sprl |
Pharmaceutical compositions
|
|
US10545815B2
(en)
|
2016-08-03 |
2020-01-28 |
Futurewei Technologies, Inc. |
System and method for data redistribution in a database
|
|
US20180071394A1
(en)
|
2016-08-25 |
2018-03-15 |
Selecta Biosciences, Inc. |
Polyester polymer matrices for the delivery of allergens
|
|
CN109922819A
(zh)
|
2016-09-27 |
2019-06-21 |
西莱克塔生物科技公司 |
用于治疗癌症的重组免疫毒素
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
WO2018093868A1
(en)
|
2016-11-16 |
2018-05-24 |
University Of Florida Research Foundation, Inc. |
Immunoglobulin proteases, compositions, and uses thereof
|
|
EP3565605A1
(en)
|
2017-01-03 |
2019-11-13 |
ethris GmbH |
Ornithine transcarbamylase coding polyribonucleotides and formulations thereof
|
|
WO2018129268A1
(en)
|
2017-01-07 |
2018-07-12 |
Selecta Biosciences, Inc. |
Patterned dosing of immunosuppressants coupled to synthetic nanocarriers
|
|
AU2018236123B2
(en)
|
2017-03-11 |
2024-04-18 |
Selecta Biosciences, Inc. |
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
|
|
AU2018347583A1
(en)
|
2017-10-13 |
2020-05-21 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector IgM responses
|
|
EP3758677A1
(en)
|
2018-02-26 |
2021-01-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Drug delivery systems
|
|
EP3790592A1
(en)
|
2018-05-09 |
2021-03-17 |
Yale University |
Particles for spatiotemporal release of agents
|
|
WO2020018587A1
(en)
|
2018-07-16 |
2020-01-23 |
Selecta Biosciences, Inc. |
Methods and compositions of mma constructs and vectors
|
|
KR20210032438A
(ko)
|
2018-07-16 |
2021-03-24 |
셀렉타 바이오사이언시즈, 인크. |
Otc 구축물 및 벡터의 방법 및 조성물
|
|
CA3138525A1
(en)
|
2019-04-28 |
2020-11-05 |
Selecta Biosciences, Inc. |
Methods for treatment of subjects with preexisting immunity to viral transfer vectors
|
|
AU2020284555A1
(en)
|
2019-05-28 |
2021-12-23 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuated anti-viral transfer vector immune response
|
|
CA3138071A1
(en)
|
2019-06-04 |
2020-12-10 |
Selecta Biosciences, Inc. |
Formulations and doses of pegylated uricase
|
|
MX2022004759A
(es)
|
2019-10-21 |
2022-08-19 |
Selecta Biosciences Inc |
Métodos y composiciones para tratar enfermedades y trastornos hepáticos.
|
|
CN118384281A
(zh)
|
2019-11-08 |
2024-07-26 |
西莱克塔生物科技公司 |
聚乙二醇化尿酸酶的制剂和剂量
|
|
MX2022010568A
(es)
|
2020-02-26 |
2022-11-30 |
Selecta Biosciences Inc |
Métodos y composiciones que usan nanoportadores sintéticos que comprenden inmunosupresor.
|
|
BR112022018070A2
(pt)
|
2020-03-11 |
2022-10-25 |
Selecta Biosciences Inc |
Métodos e composições relacionados a nanoveículos sintéticos
|
|
EP4215208A4
(en)
|
2020-09-21 |
2024-11-20 |
Shanghai Bao Pharmaceuticals Co., Ltd. |
PHARMACEUTICAL COMBINATION AND USE THEREOF
|
|
WO2022098901A1
(en)
|
2020-11-04 |
2022-05-12 |
Selecta Biosciences, Inc. |
Compositions for reducing immune responses against immunoglobulin proteases
|
|
AU2022206197A1
(en)
|
2021-01-05 |
2023-07-13 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
|
MX2023011930A
(es)
|
2021-04-09 |
2024-03-11 |
Selecta Biosciences Inc |
Nanoportadores sintéticos que comprenden un inmunosupresor en combinación con antagonistas del receptor de il-2 de alta afinidad para mejorar la tolerancia inmune.
|
|
EP4079848A1
(en)
|
2021-04-22 |
2022-10-26 |
Genovis Ab |
Immunoglobulin cleaving enzyme
|
|
JP2024539646A
(ja)
|
2021-10-12 |
2024-10-29 |
カーティザン セラピューティクス，インコーポレーテッド |
ウイルスベクター投薬プロトコル
|
|
US20230141563A1
(en)
|
2021-10-12 |
2023-05-11 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
|
US20230357437A1
(en)
|
2022-03-09 |
2023-11-09 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
|
AU2023321906A1
(en)
|
2022-08-11 |
2025-03-27 |
Cartesian Therapeutics, Inc. |
Compositions and methods related to immunoglobulin proteases and fusions thereof
|